Patents by Inventor Michael Deguzman

Michael Deguzman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10105447
    Abstract: Modified canine leptin polypeptides and formulations and uses thereof, are provided including polyethylene glycol (PEG) modified canine leptin polypeptides, wherein the PEG moiety is covalently attached to a para-acetyl-phenylalanine (pAF) residue of the polypeptide, and related compositions and methods useful in treating companion animal obesity and other leptin-related disorders.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: October 23, 2018
    Assignees: ELANCO US INC., AMBRX, INC.
    Inventors: Michael Bledsoe, Peter Connor Canning, Michael Deguzman, Nick Knudsen, Ianina Valenta
  • Publication number: 20150366983
    Abstract: Modified canine leptin polypeptides and formulations and uses thereof, are provided including polyethylene glycol (PEG) modified canine leptin polypeptides, wherein the PEG moiety is covalently attached to a para-acetyl-phenylalanine (pAF) residue of the polypeptide, and related compositions and methods useful in treating companion animal obesity and other leptin-related disorders.
    Type: Application
    Filed: March 12, 2014
    Publication date: December 24, 2015
    Inventors: Michael BLEDSOE, Peter Connor CANNING, Michael DEGUZMAN, Nick KNUDSEN, Ianina VALENTA
  • Publication number: 20150299288
    Abstract: Modified insulin polypeptides and their uses thereof are provided
    Type: Application
    Filed: December 19, 2014
    Publication date: October 22, 2015
    Applicant: AMBRX, INC.
    Inventors: Zhenwei MIAO, Denise KRAWITZ, Vadim KRAYNOV, Tian FENG, Bee-Cheng SIM, Lillian SKIDMORE, Anna-Maria A. HAYS PUTNAM, Nick KNUDSEN, Michael DEGUZMAN
  • Patent number: 8946148
    Abstract: Modified insulin polypeptides and their uses thereof are provided.
    Type: Grant
    Filed: November 20, 2008
    Date of Patent: February 3, 2015
    Assignee: Ambrx, Inc.
    Inventors: Zhenwei Miao, Denise Krawitz, Vadim Kraynov, Feng Tian, Bee-Cheng Sim, Lillian Skidmore, Anna-Maria A. Hays Putnam, Nick Knudsen, Michael Deguzman
  • Publication number: 20100298212
    Abstract: Modified insulin polypeptides and their uses thereof are provided
    Type: Application
    Filed: November 20, 2008
    Publication date: November 25, 2010
    Applicant: AMBRX, INC.
    Inventors: Zhenwei Miao, Denise Krawitz, Vadim Kraynov, Tian Feng, Bee-Cheng Sim, Lillian Skidmore, Anna-Maria A. Hays Putnam, Nick Knudesen, Michael Deguzman